Community SpotlightPublicationsResearch NewsResearch Spotlight Down syndrome collaborators now published in Alzheimer’s and Dementia “Adapting prescribing criteria for amyloid‐targeted antibodies for adults with Down syndrome” published in the journal…Kate O’NeillMarch 15, 2024
Research NewsCommunity Spotlight Reuters Article: Barriers to Latest Alzheimer’s Treatments for Down Syndrome Community Hampus Hillerstrom, CEO of LuMind IDSC Foundation and father to a child with Down syndrome,…Shannon BergstresserNovember 14, 2023
Community Spotlight LuMind IDSC names new Director of Community Programs Following a five-month, national search, LuMind IDSC Down Syndrome Foundation announced the appointment of Christina…Kate O’NeillSeptember 21, 2023
Community SpotlightResearch NewsResearch Spotlight Boston Globe OpEd People with Down Syndrome Now Left Out of Treatment LuMind IDSC and The Arc of Northeast collaborated on an OpEd that was recently published…Kate O’NeillSeptember 18, 2023
Press ReleaseResearch News MapHabit Study: Assistive Technology Has Positive Outcomes for Children with Down Syndrome Study Finds Assistive Technology Has Positive Outcomes for Children with Down Syndrome and Their Caregivers …Kate O’NeillJune 2, 2023
Research NewsPress ReleaseResearch Spotlight Expert panel addresses inequitable access to Alzheimer’s drugs for adults with Down syndrome Seeking to rectify existing federal and state policies which prevent people with intellectual disabilities from…Kate O’NeillJune 1, 2023
Research NewsResearch Spotlight LuMind IDSC Statement re: Donanemab Phase 3 Results Pharmaceutical company Eli Lilly today announced results of a phase III clinical trial that proves…Kate O’NeillMay 3, 2023